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Abstract Background Despite the importance placed on
the concept of the multidisciplinary team in relation to
intermediate care (IC), little is known about community
pharmacists’ (CPs) involvement. Objective To determine
CPs’ awareness of and involvement with IC services,
perceptions of the transfer of patients’ medication infor-
mation between healthcare settings and views of the
development of a CP–IC service. Setting Community
pharmacies in Northern Ireland. Methods A postal ques-
tionnaire, informed by previous qualitative work was
developed and piloted. Main outcome measure CPs’
awareness of and involvement with IC. Results The
response rate was 35.3 % (190/539). Under half (47.4 %)
of CPs ‘agreed/strongly agreed’ that they understood the
term ‘intermediate care’. Three quarters of respondents
were either not involved or unsure if they were involved
with providing services to IC. A small minority (1.2 %) of
CPs reported that they received communication regarding
medication changes made in hospital or IC settings ‘all of
the time’. Only 9.5 and 0.5 % of respondents ‘strongly
agreed’ that communication from hospital and IC,
respectively, was sufficiently detailed. In total, 155
(81.6 %) CPs indicated that they would like to have greater
involvement with IC services. ‘Current workload’ was
ranked as the most important barrier to service develop-
ment. Conclusion It was revealed that CPs had little
awareness of, or involvement with, IC. Communication of
information relating to patients’ medicines between set-
tings was perceived as insufficient, especially between IC
and community pharmacy settings. CPs demonstrated
willingness to be involved with IC and services aimed at
bridging the communication gap between healthcare
settings.
Keywords Community pharmacy  Healthcare interface 
Intermediate care  Medicines management 
Questionnaire  United Kingdom
Impacts on practice
• Intermediate care is an evolving healthcare setting that
provides an alternative to hospital for older adults, yet
community pharmacists have little awareness of, or
involvement with such services.
• Community pharmacists could have a role to play in
providing medicines management services to patients
in intermediate care, which may improve the currently
suboptimal communication of information relating to
patients’ medications between hospital, intermediate
care, and primary care settings.
Introduction
Intermediate care (IC) is a care setting that has evolved in
response to the ageing population, the increasing pressure
faced by acute healthcare services and the resulting need
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for alternatives to hospital-based care. Whilst various ter-
minologies are used to describe similar care settings
globally [1], IC is broadly defined in the United Kingdom
(UK) as ‘a range of integrated services to prevent unnec-
essary hospital admission, promote faster recovery from
illness, support timely discharge and maximise indepen-
dent living’ [2]. Despite the importance placed on the
concept of the multidisciplinary team in IC, previous work
has highlighted how the pharmacy profession has not been
integrated into this care setting [1, 3, 4]. This lack of
pharmacy involvement is concerning, given that various
aspects of medicines management within the IC setting
may be suboptimal [3].
The majority of patients in IC facilities are admitted
directly from hospital, and over 70 % of patients return
home following discharge from IC [5]. Once home, it can
be assumed that the ongoing medicines management of
these individuals will be provided by their primary
healthcare professionals, including general practitioners
(GPs) and community pharmacists (CPs). Patients’ medi-
cation regimens are often the subject of change following a
period of care in hospital or an IC facility. Sixty percent of
patients experience five or more changes to their medicines
between admission to and discharge from hospital [6]. It is
therefore imperative that information relating to patients’
current medications is communicated effectively to their
primary healthcare professionals to ensure continuity of
care.
In Northern Ireland (NI), previous qualitative work
with CPs has suggested that they have a limited awareness
of, and involvement with, IC [3]. Furthermore, it was
revealed that CPs frequently experienced challenges
relating to the communication of information at the vari-
ous healthcare interfaces. CPs described often being ‘left
out of the loop’, not only in relation to IC, but also the
communication of patients’ medication information at the
points of transfer between secondary care, IC and primary
care. In an attempt to obtain up-to-date information
relating to patients’ medications, CPs described how the
responsibility fell to them to ‘chase things up.’ Finally,
this study’s findings also suggested that CPs could ‘close
the loop’ by bridging the gap between healthcare settings,
through increased involvement in IC and services targeted
at both IC and communication across the healthcare
interface [3].
Ineffective communication relating to patients’ medi-
cations between healthcare settings may adversely affect
patient care [7, 8]. Efforts aimed at improving communi-
cation may therefore minimise the potential for medica-
tion-related harm. CPs are ideally placed to potentially
improve patient-related outcomes by facilitating seamless
care when patients are transitioning through the healthcare
interfaces [9].
Aim of the study
The aim of the present study was to further explore and
quantify the issues that emerged through the previous quali-
tative investigation in order to gain a more complete under-
standing of CPs’ awareness of and involvement in IC facilities
in NI and their experiences of the transfer of information at the
various existing healthcare interfaces. Additionally, this study
aimed to determine CPs’ views of the development of a
community pharmacy-IC medicines management service,
including their perceived level of confidence in their ability to
conduct tasks that may be part of such a service.
Ethics approval
Ethical approval was obtained from the School of Phar-
macy Ethics Committee, Queen’s University Belfast.
Methods
This cross-sectional study consisted of an anonymous, self-
administered, postal questionnaire. The questionnaire was
informed by the findings of previous qualitative work
conducted in the area [3] and consisted of four sections
(Fig. 1). Questions were largely formatted as either fixed-
response options or five-point Likert scales. Two open-
ended questions were also included, asking respondents to
share their views of communication across the healthcare
interface and the development of a community pharmacy-
IC service. The questionnaire was piloted with six phar-
macists, to assess face and content validity [10].
Community pharmacies were identified through the Phar-
maceutical Society of Northern Ireland (PSNI), the regulatory
and professional body for pharmacists in NI. The PSNI pro-
vide a searchable register of pharmacists and pharmacy pre-
mises on their website, however, pharmacists are not linked to
the pharmacy within which they practise, nor are their contact
details provided. For this reason, the questionnaire was sent by
post to every community pharmacy premises in NI (n = 539),
addressed to ‘the pharmacist in charge’. Questionnaires were
posted on two occasions, 3 weeks apart, between January and
February 2015. On the first occasion, each pharmacy was sent
a pack containing: a letter of invitation, a token incentive
(coffee sachet and biscuit), the questionnaire, and a pre-paid
return envelope. Informed consent for participation in the
study was assumed on receipt of the completed questionnaire.
Responses were entered into SPSS Version 20.0 (SPSS
Inc., Chicago, IL, USA) for analysis. Missing responses
were coded as such and omitted from the analysis. A ran-
dom sample of 10 % of the questionnaires in the electronic
database was compared against the paper questionnaires to
assess the accuracy of data entry. An error rate of 0.28 %
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was revealed, and deemed acceptable. Descriptive analyses
were conducted to describe the demographics of respon-
dents. Responses to Likert items were analysed by calcu-
lating the percentage agreement or disagreement to each
statement. Wilcoxon signed-ranked tests were used to
explore differences in scores for identical statements
relating to different settings (i.e. IC vs. hospital). Scores
were calculated based upon the CPs’ responses on a scale
of 1–5, where a lower score indicated a greater agreement
with a statement and vice versa. Respondents who
answered ‘don’t know’ were excluded from this analysis.
Differences were considered significant if p\ 0.05.
To determine their perceived level of confidence in their
ability (i.e. self-efficacy) to contribute to a IC service,
respondents were asked to rate their level of confidence in
their ability to provide various aspects of a hypothetical IC
service, in line with Bandura’s Social Cognitive Theory
[11]. The response format for each of these items was a
10-point self-efficacy scale, where 1 indicated ‘cannot do
at all’ and 10 indicated ‘highly certain can do’ [12].
Responses to open-ended questions were entered into
Microsoft Word (2010) and analysed for emergent
themes. Verbatim quotations were used to illustrate iden-
tified themes. All respondents were assigned a unique
identifier to ensure anonymity.
Results
Response rate and demographics
A total of 190 completed questionnaires were returned,
corresponding to a response rate of 35.3 %. The demo-
graphic details pertaining to the respondents are provided
in Table 1. Data from the PSNI relating to all registered
pharmacists in NI was obtained to allow for a demographic
comparison with the study participants. The information
available related to pharmacists working in all sectors, and
not solely CPs, who comprised 59 % of those pharmacists
registered with the PSNI in 2014.
Awareness of and involvement with intermediate
care
Less than half (90; 47.4 %) of CPs either ‘agreed’ or
‘strongly agreed’ that they understood what was meant by
the term ‘intermediate care’, and fewer (70; 36.8 %)
‘agreed’ or ‘strongly agreed’ that they were aware of the
IC facilities in their area. Despite these findings, 152
(80.0 %) CPs ‘agreed’ or ‘strongly agreed’ that CPs
(generally) should have greater involvement with IC ser-
vices. A similar number (155; 81.6 %) ‘agreed’ or
‘strongly agreed’ that they (personally) would like to be
more involved with IC services (Table 2).
The majority of CPs (142; 74.7 %) were either not
providing any services to IC facilities, or were unsure if
they were providing services. Of the 46 (24.2 %) CPs who
reported that they provided services to IC facilities, the
most frequently provided service was the dispensing of
medication to patients who would regularly use their
pharmacy and were subsequently admitted to IC (41;
89.1 %).
Communication across the healthcare interface
CPs were asked to indicate who would typically inform
them when a patient who regularly used their pharmacy
was admitted to IC or hospital. Figure 2 shows the
Fig. 1 Overview of
questionnaire content. Key: CP
community pharmacist, IC
intermediate care
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Table 1 Demographic profile
of study respondents (n = 190)
compared to all pharmacists
registered with the PSNI
(n = 2003)
Study respondents
n (%)
PSNI
n (%)
Gender
Male 79 (41.6) 666 (33.3)
Female 111 (58.4) 1337 (66.7)
Age (years) Age
\25 11 (5.8) B25 144 (7.2)
25–34 71 (37.4) 26–35 873 (43.6)
35–44 55 (28.9) 36–45 525 (26.2)
45–54 42 (22.1) 46–55 326 (16.3)
55–64 11 (5.8) 56–65 119 (5.9)
C65 0 (0.0) 66–70 4 (0.2)
C71 12 (0.6)
Years practising
B5 42 (22.1) a
6–11 45 (23.7)
12–17 35 (18.4)
18–23 23 (12.1)
24–29 26 (13.7)
30–35 14 (7.4)
C36 2 (1.1)
Missing 3 (1.6)
Type of community pharmacy
Independent 106 (55.8) a
Multiple 84 (44.2)
Location of community pharmacy a
Urban 84 (44.2)
Suburban 43 (22.6)
Rural 62 (32.6)
Missing 1 (0.5)
Average number of prescription items
dispensed on a weekday
\50 4 (2.1) a
50–199 57 (30.0)
200–400 84 (44.2)
[400 38 (20.0)
Missing 7 (3.7)
Age profile of patients using pharmacy
Majority\65 years 42 (22.1) a
Majority C65 years 142 (74.7)
Missing 6 (3.2)
Additional prescribing qualifications
None 173 (91.1) 1790 (89.4)
Supplementary prescriber 7 (3.7) 14 (0.7)
Independent prescriber 10 (5.3) 199 (9.9)
Currently using prescribing qualification
(of those qualified)
Yes 8 (29.6) a
No 19 (70.4)
a Data unavailable from the Pharmaceutical Society of Northern Ireland
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categories of informants and the proportion of CPs who
indicated that these individuals would typically notify them
of a patient’s admission.
Approximately one-third of respondents reported that
they were ‘never informed’ when a patient who used their
pharmacy was admitted to either hospital or IC. CPs
described ‘other’ informants as including ‘home-help’,
nursing home staff and pharmacy delivery drivers.
CPs were asked, in general, how frequently they would
be informed of changes made to patients’ medicines at
discharge from hospital and IC. Seventy-five (39.5 %) CPs
indicated that changes in the dose or frequency of
medicines were communicated from hospital ‘most of the
time’. Similarly, 70 (36.8 %) and 63 (33.2 %) respondents
reported that new medicines and stopped medicines,
respectively, were communicated ‘most of the time’. On
average, 36.5 % of CPs reported that changes to patients’
medication regimens (of any type) made in hospital were
communicated ‘most of the time’. Considering changes
made in the IC setting, the corresponding value was less
than half that relating to hospitals (17.4 %). Combining
both hospital and IC, only 1.2 % of CPs reported that they
received communication regarding medication changes
made ‘all of the time’.
CPs were also asked the methods by which patients’
medication information was transferred to them at dis-
charge from hospital or IC, in those instances when
information was indeed communicated. Respondents could
select more than one option. A telephone call was the most
frequently reported, as 156 (82.1 %) and 54 (28.4 %) CPs
indicated that they received communication via this
method from both hospital and IC, respectively. Email was
the least popular as only 17 (8.9 %) and one (0.5 %)
CP(s) indicated that they receive communications via this
method from hospital and IC, respectively.
CPs were asked to indicate their views on additional
aspects of communication across the healthcare interface.
One hundred and six (55.7 %) respondents ‘agreed’ or
‘strongly agreed’ that communication between GP surg-
eries and their community pharmacy was good. However,
only 26 (13.7 %) ‘agreed’ or ‘strongly agreed’ that com-
munication between IC facilities and their community
pharmacy was good. Less than one in ten (9.5 %) CPs
‘strongly agreed’ with the statement: ‘At patient discharge,
the level of detail provided in medication communication
information from hospital is sufficient for my needs as a
community pharmacist.’ For IC, this figure fell to 0.5 %
(Table 3).
For both hospital and IC settings, the vast majority of
CPs indicated that they often had to contact a GP to obtain
information relating to patients’ medication after dis-
charge. Only 19 (10.0 %) respondents ‘strongly agreed’
that information contained in discharge summaries from
hospitals was clearly presented. Only four (2.1 %) and one
(0.5 %) respondents ‘strongly agreed’ that information
from hospitals and IC, respectively, was communicated to
them in a timely manner. The vast majority (144; 75.8 %
and 152; 80.0 %) either ‘strongly agreed’ or ‘agreed’ that
they would like to receive more information relating to
patients’ medications at discharge from hospital and IC,
respectively.
Excluding those who answered ‘don’t know’, a total of
150 (78.9 %) respondents’ views were compared in
Table 2 CPs’ agreement with statements regarding awareness of and involvement with intermediate care
Statement SA
n (%)
A
n (%)
NAD
n (%)
D
n (%)
SD
n (%)
M
n (%)
I understand what is meant by the term ‘intermediate care’ 11 (5.8) 79 (41.6) 34 (17.9) 53 (27.9) 12 (6.3) 1 (0.5)
I am aware of the intermediate care facilities in my local area 9 (4.7) 61 (32.1) 28 (14.7) 78 (41.1) 12 (6.3) 2 (1.1)
I think community pharmacists should have greater involvement with
intermediate care facilities/services
64 (33.7) 88 (46.3) 29 (15.3) 8 (4.2) 0 (0.0) 1 (0.5)
I would like to have greater involvement with intermediate care facilities/
services
63 (33.2) 92 (48.4) 26 (13.7) 8 (4.2) 0 (0.0) 1 (0.5)
SA strongly agree, A agree, NAD neither agree nor disagree, D disagree, SD strongly disagree, M missing
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Fig. 2 Main informants for the CP when a patient who used their
pharmacy was admitted to hospital or an IC facility. Key: GP general
practitioner, IC Intermediate care
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relation to the statements: ‘Overall I think the communi-
cation between IC facilities and my community pharmacy
is good’, and ‘Overall, I think the communication between
hospitals and my community pharmacy is good’. Signifi-
cantly more CPs were in agreement with the statement in
relation to hospitals (median score 2.5; interquartile range
2.0–3.0) compared with IC facilities (median score 3.0;
interquartile range 3.0–4.0), z = -6.67, p\ 0.001.
Respondents were asked if they had any further com-
ments on communication across the healthcare interface.
Three themes emerged from the data: ‘left out of the loop’,
‘chasing things up’ and ‘closing the loop’. Figure 3 high-
lights these themes with supporting quotations from
respondents.
Community pharmacy: intermediate care service
implementation
When asked about their confidence in conducting specific
tasks with patients and/or staff in IC facilities, CPs were
generally highly confident in their ability to conduct all
those suggested, as evident from the mean self-efficacy
scores for each item (Table 4), with the possible score
range being 1-10, where 1 indicated ‘cannot do at all’ and
10 indicated ‘highly certain can do’ [12].
CPs were then provided with a list of potential bar-
riers to the development of an IC service and asked to
rate each in order of importance to them. ‘Current
workload’ was rated by the majority (58; 40.0 %) of
Table 3 CPs’ agreement with statements regarding communication between community pharmacy and various healthcare interfaces
Statement SA
n (%)
A
n (%)
NAD
n (%)
D
n (%)
SD
n (%)
DK
n (%)
M
n (%)
Score
(median; IQR)
Wilcoxon signed-ranks
test (two tailed)
Communication is good between my pharmacy and
GPs 17 (8.9) 89 (46.8) 31 (16.3) 36 (18.9) 17 (8.9) – – – –
IC 1 (0.5) 25 (13.2) 53 (27.9) 48 (25.3) 24 (12.6) 39 (20.5) – 3.0; 3.0–4.0 Z = -6.67, p\ 0.01
Hospital 6 (3.2) 87 (45.8) 48 (25.3) 35 (18.4) 13 (6.8) 1 (0.5) – 2.5; 2.0–3.0
Sufficient information is communicated to CP at discharge from
Hospital 18 (9.5) 88 (46.3) 24 (12.6) 35 (18.4) 24 (12.6) – 1 (0.5) 2.0; 2.0–4.0 Z = -7.02, p\ 0.001
IC 1 (0.5) 25 (13.2) 48 (25.3) 42 (22.1) 28 (14.7) 45 (23.7) 1 (0.5) 3.0; 3.0–4.0
I often have to contact GP to obtain medication information on patients’ medication after discharge from
Hospital 78 (41.1) 71 (37.4) 19 (10.0) 19 (10.0) 2 (1.1) – 1 (0.5) 2.0; 1.0–2.0 Z = -1.57, p = 0.116
IC 63 (33.2) 58 (30.5) 24 (12.6) 4 (2.1) 1 (0.5) 38 (20.0) 2 (1.1) 2.0; 1.0–2.0
Information contained in discharge summaries is clearly presented from
Hospital 19 (10.0) 109 (57.4) 32 (16.8) 22 (11.6) 2 (1.1) 4 (2.1) 2 (1.1) 2.0; 2.0–3.0 Z = 6.29, p\ 0.01
IC – 35 (18.4) 63 (33.2) 21 (11.1) 6 (3.2) 63 (33.2) 2 (1.1) 3.0; 2.0–3.0
Information relating to patients’ medications following discharge is communicated to me in a timely manner
Hospital 4 (2.1) 81 (42.6) 46 (24.2) 41 (21.6) 15 (7.9) 2 (1.1) 1 (0.5) 3.0; 2.0–4.0 Z = -4.96, p\ 0.001
IC 1 (0.5) 22 (11.6) 63 (33.2) 35 (18.4) 15 (7.9) 52 (27.4) 2 (1.1) 3.0; 3.0–4.0
I would like to receive more information on patients’ medications at discharge from
Hospital 86 (45.3) 58 (30.5) 21 (11.1) 22 (11.6) 2 (1.1) – 1 (0.5) 2.0; 1.0–2.0 Z = -4.52, p\ 0.001
IC 97 (51.1) 55 (28.9) 18 (9.5) 2 (1.1) – 17 (8.9) 1 (0.5) 1.0; 1.0–2.0
It’s important for me to know a patient’s diagnosis/reason for admission to
Hospital 45 (23.7) 95 (50.0) 37 (19.5) 11 (5.8) – – 2 (1.1) 2.0; 1.0–3.0 Z = -2.53, p\ 0.05
IC 44 (23.2) 81 (42.6) 45 (23.7) 9 (4.7) – 10 (5.3) 1 (0.5) 2.0; 2.0–3.0
It’s important for me to know the reason(s) for changes made to patients’ medication in
Hospital 72 (37.9) 91 (47.9) 19 (10.0) 5 (2.6) 1 (0.5) – 2 (1.1) 2.0; 1.0–2.0 Z = -2.24, p\ 0.05
IC 69 (36.3) 85 (44.7) 20 (10.5) 5 (2.6) 1 (0.5) 9 (4.7) 1 (0.5) 2.0; 1.0–2.0
I think CPs should have access to patients’ medical records in community pharmacies
100 (52.6) 58 (30.5) 19 (10.0) 8 (4.2) 3 (1.6) 1 (0.5) 1 (0.5) – –
I think patients should be registered with one community pharmacy to ensure continuity of care at healthcare interfaces
77 (40.5) 60 (31.6) 31 (16.3) 15 (7.9) 3 (1.6) 3 (1.6) 1 (0.5) – –
SA strongly agree, A agree, NAD neither agree nor disagree, D disagree, SD strongly disagree, DK don’t know, M missing, IQR interquartile
range, GP general practitioner, IC intermediate care, CP community pharmacist
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respondents as the most important barrier. Despite com-
ments suggesting that such a service would be concep-
tually viable, CPs reported that several barriers would
need to be addressed prior to the implementation of such
services. Reimbursement of services and the additional
staff needed in order to provide such services were
highlighted frequently by respondents. Nevertheless,
comments received from respondents indicated that CPs
viewed themselves as being ideally placed to being
involved with IC services and/or services that would
facilitate patients’ transitions across the healthcare
interface:
Community pharmacy is ideally placed to deal with
issues in intermediate care and should have an
important role to play. (R55)
• “..we don’t have much dealings with intermediate care facilities.” (R157)
• “Communications from hospitals is still poor but has improved significantly in the 
last few years. Hospitals differ in their quality of communication and better 
communication between different levels of care is essential.” (R110)
• “When communication takes place it is generally of high quality. Too many 
patients fall through the gaps with no...information being provided.” (R51)
• “Sometimes hospitals will phone us, sometimes not. Sometimes the GP gets in 
touch, sometimes not. Sometimes the patient will inform us, then we have to go 
on a  time-consuming 'information hunt' to the GP.” (R177)
"Left out of the loop"
• “There are too many medication errors due to lack of communication...it happens 
regularly that I am not informed of medication changes and the patient does not 
recieve the change until I chase up missing scripts.” (R22)
• “Usually hospital dispenses one week of medication- not always, therefore I have 
to spend half a day chasing the discharge letter and new script from the GP 
surgery.” (R69)
• “Biggest problem occurs with patients who recieve mediboxes. If we're not 
informed patient in hospital we don't know not to make it up. Quite often elderly 
patients have limited local family support, so left entirely to us to organise scripts 
[prescriptions] on discharge... the hospital expect us to do this within a a few 
hours which is impossible..” (R88) 
"Chasing things up"
• “I think it is a very important step moving forward that community pharmacies 
have access to patient medication files...It enables a more competent and full 
service to the patient.” (R98)
• “It is vital that pharmacists are included in this communication. We can prevent 
errors with medication prescribed from GP surgery from discharge letters...and 
provide info [sic] to patient on medication changes.” (R36)
• “There needs to be better organisation between healthcare settings... there is not 
enough information or contact between healthcare settings to allow good and 
'joined up' patient care.”(R6)
"Closing the loop"
Fig. 3 CPs’ views of
communication between the
various healthcare interfaces
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[CPs] are extremely competent in providing advice
rather than just dispensing. We have a fountain of
knowledge yet rarely get to use it. (R73)
[CPs] are ideally placed to follow up on discharge
medication reviews and prevent readmission due to
medication errors. (R170)
Discussion
The study highlighted a low awareness of and involvement
with IC services amongst CPs in NI. This finding is
unsurprising given the confusion surrounding the termi-
nology used to describe IC [1]. Despite its presence within
the UK for over a decade, IC does not relate to a single
healthcare service or setting [13]. However, a majority of
CPs reported willingness for the profession to have greater
involvement with IC.
The questionnaire generated a response rate of 35.3 %.
Whilst not optimal, this response rate is typical of postal
questionnaires administered to the sample population
[14–17] and the demographic profile of the respondents
was not dissimilar to that provided by the PSNI.
The dispensing of medicines to patients in IC accounted
for the majority of ‘services’ provided by CPs to IC facilities.
In recent times, pharmacists have adopted a variety of
enhanced roles, including prescribing, which reflect their
expertise surrounding medicines. Whilst not widely imple-
mented in IC, pharmacist prescribing has become an
increasingly commonplace practice in both primary and
secondary care settings [18, 19]. Notably, it has been shown
that patients generally regard pharmacist prescribing as an
acceptable alternative to medical prescribing [20, 21]. This
study suggests that CPs are keen to expand their professional
boundaries, however, it remains the case that the majority of
those who have acquired prescribing qualifications are cur-
rently not using them, perhaps due to a lack of opportunities
or lack of access to clinical information in the community
pharmacy setting necessary to facilitate a prescribing role.
CPs viewed communication across the various health-
care interfaces to be deficient. This finding reiterates that
reported in the previous qualitative study [3], where it was
described how CPs were not routinely informed when
patients were admitted into hospital or IC. This issue is not
unique to NI [21]. Irrespective of the setting, only a
minority of CPs reported that they were informed of
changes to patients’ medication regimens ‘all of the time’
at discharge. This poses a risk to patients as communica-
tion breakdown is a leading cause of adverse events at
transitions of care [23]. Furthermore, this study provided
additional evidence of CPs ‘chasing things up’ with GPs as
a means of accessing information. This ad-hoc method is
both inefficient and potentially hazardous. In recognition of
this, there have been calls for pharmacists to have access to
patients’ records [24]. Additionally, electronic communi-
cation of discharge letters has been shown to facilitate the
timely transfer of information between settings [8, 25].
Both the content and level of detail contained in com-
munications regarding patients’ medicines was found to be
important to CPs. A study by Munday et al. [26] also
reported that the majority of CPs considered it necessary to
be informed of the reasons underpinning medication
changes, yet few received such information. Urban et al.
[27] also reported that the provision of information to
community pharmacies from hospitals regarding medica-
tion was inconsistent and lacking in quality. By routinely
providing such level of detail, via a discharge summary,
CPs will be able to ascertain whether apparent changes
made to medicines are intentional, therefore negating the
need to ‘chase things up’.
CPs considered themselves ideally placed and capable
of providing services to IC patients and/or staff, as evi-
denced by the high levels of reported self-efficacy. More
than 10 years ago, the Royal Pharmaceutical Society of
Great Britain outlined how pharmacists could contribute to
IC services [28]. Whilst there remains a lack of involve-
ment from the community pharmacy sector of the profes-
sion, there have been emerging examples of innovative
models of clinical pharmacist-led care pathways under
development in England [29] and NI [30]. This study
suggests that the most pertinent barrier to CP involvement
is the existing workload that CPs currently face. Further
research should therefore aim to determine whether CP–IC
services are feasible and have the ability to improve patient
outcomes by facilitating seamless care across the health-
care interfaces.
Strengths and limitations
This study has provided quantitative evidence which fur-
ther supports the findings of the previous qualitative
research [3, 4]. Whilst effortswere taken to optimise the
response rate, the low response rate achieved may limit the
Table 4 CPs’ self-efficacy scores for a range of IC service tasks
Task Self-efficacy mean
score (±SD)
Counseling IC patients on their medicines 8.68 (±1.59)
Providing education to IC staff 8.40 (±1.78)
Reconciling IC patients’ medicines 8.55 (±1.65)
Providing prescribing advice/make
recommendations to prescribers on
appropriateness of IC patients’ medicines
7.65 (±2.28)
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generalisability of the findings. A poor awareness of IC
among CPs may itself have hindered the response rate. The
potential for differences in the respondent sample should
be acknowledged when interpreting the data, as should the
possibility of social desirability bias.
Conclusion
This study supports the findings of the previous qualitative
work whereby CPs in NI demonstrated a lack of awareness
of IC and the majority had no involvement with local IC
services. In the study described here, the communication of
information relating to patients’ medications between
healthcare settings was reported to be suboptimal both in
quantity and quality, particularly in relation to communi-
cation between IC settings and community pharmacies.
CPs would like to have greater involvement with IC ser-
vices and services aimed at bridging the communication
gap between the healthcare interfaces. However, important
barriers exist that would need to be addressed prior to the
development of any service.
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